Repository logo
 

GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain.

Published version
Peer-reviewed

Type

Article

Change log

Authors

Dar, Ghulam Hassan 
Mendes, Cláudia C 
Kuan, Wei-Li 
Conceição, Mariana 

Abstract

Extracellular vesicles (EVs) are biological nanoparticles with important roles in intercellular communication, and potential as drug delivery vehicles. Here we demonstrate a role for the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in EV assembly and secretion. We observe high levels of GAPDH binding to the outer surface of EVs via a phosphatidylserine binding motif (G58), which promotes extensive EV clustering. Further studies in a Drosophila EV biogenesis model reveal that GAPDH is required for the normal generation of intraluminal vesicles in endosomal compartments, and promotes vesicle clustering. Fusion of the GAPDH-derived G58 peptide to dsRNA-binding motifs enables highly efficient loading of small interfering RNA (siRNA) onto the EV surface. Such vesicles efficiently deliver siRNA to multiple anatomical regions of the brain in a Huntington's disease mouse model after systemic injection, resulting in silencing of the huntingtin gene in different regions of the brain.

Description

Keywords

Animals, Brain, Cell Line, Tumor, Disease Models, Animal, Drug Delivery Systems, Extracellular Vesicles, Glyceraldehyde-3-Phosphate Dehydrogenases, HEK293 Cells, HeLa Cells, Humans, Huntingtin Protein, Huntington Disease, Mesenchymal Stem Cells, Mice, Inbred C57BL, Phosphatidylserines, Protein Binding, RNA, Small Interfering, Mice

Journal Title

Nat Commun

Conference Name

Journal ISSN

2041-1723
2041-1723

Volume Title

12

Publisher

Springer Science and Business Media LLC
Sponsorship
Medical Research Council (MR/M007715/1)
Relationships
Is derived from: